Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2017 | 41 | 0.590 |
Why?
|
| Mad2 Proteins | 1 | 2017 | 33 | 0.580 |
Why?
|
| Cell Cycle Proteins | 2 | 2017 | 2116 | 0.540 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 256 | 0.380 |
Why?
|
| Kidney Neoplasms | 3 | 2017 | 3107 | 0.310 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2017 | 2388 | 0.310 |
Why?
|
| DNA Damage | 2 | 2013 | 1981 | 0.300 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 1900 | 0.230 |
Why?
|
| Apoptosis | 3 | 2017 | 7741 | 0.220 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 4956 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 3653 | 0.180 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 5000 | 0.180 |
Why?
|
| Breast Neoplasms | 3 | 2013 | 16183 | 0.160 |
Why?
|
| Transcription Factors | 2 | 2014 | 5434 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2013 | 12087 | 0.150 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2014 | 165 | 0.130 |
Why?
|
| Chromosomal Instability | 1 | 2017 | 229 | 0.130 |
Why?
|
| Aneuploidy | 1 | 2017 | 377 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 744 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 626 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2014 | 234 | 0.110 |
Why?
|
| Staurosporine | 1 | 2013 | 147 | 0.110 |
Why?
|
| Snail Family Transcription Factors | 1 | 2012 | 120 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 2448 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 589 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2017 | 2136 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2013 | 892 | 0.090 |
Why?
|
| Phosphorylcholine | 1 | 2011 | 56 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2017 | 1628 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2017 | 5658 | 0.090 |
Why?
|
| Caspases | 1 | 2013 | 677 | 0.090 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 437 | 0.090 |
Why?
|
| Camptothecin | 1 | 2013 | 540 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 5757 | 0.080 |
Why?
|
| HeLa Cells | 1 | 2012 | 1685 | 0.080 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2011 | 366 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 894 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2017 | 7236 | 0.080 |
Why?
|
| Autophagy | 1 | 2014 | 910 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 1265 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 2452 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 1469 | 0.070 |
Why?
|
| Mice | 4 | 2017 | 35465 | 0.070 |
Why?
|
| Cell Line, Tumor | 5 | 2014 | 14832 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 181 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2006 | 67 | 0.060 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2006 | 99 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 1942 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 303 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2015 | 2417 | 0.060 |
Why?
|
| Bronchi | 1 | 2006 | 324 | 0.060 |
Why?
|
| Animals | 5 | 2017 | 61714 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 3030 | 0.060 |
Why?
|
| Mice, Nude | 3 | 2015 | 4329 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 5405 | 0.050 |
Why?
|
| Humans | 10 | 2024 | 270033 | 0.040 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2024 | 625 | 0.040 |
Why?
|
| Neoplasms | 1 | 2024 | 15902 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 1 | 2006 | 2650 | 0.030 |
Why?
|
| Indoles | 2 | 2015 | 1026 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2014 | 39 | 0.030 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2014 | 35 | 0.030 |
Why?
|
| Elongin | 1 | 2014 | 10 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2014 | 88 | 0.030 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2014 | 53 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 5860 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2006 | 4958 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2015 | 423 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 739 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2006 | 1801 | 0.030 |
Why?
|
| Texas | 1 | 2024 | 6430 | 0.030 |
Why?
|
| Female | 3 | 2013 | 148486 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 594 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 1555 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 622 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2015 | 958 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 593 | 0.020 |
Why?
|
| Pyrroles | 1 | 2015 | 587 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 714 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 1461 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 1052 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1017 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2024 | 3553 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 1385 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5566 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 2089 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 1193 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 2197 | 0.020 |
Why?
|
| B7-H1 Antigen | 1 | 2015 | 1081 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1035 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 1655 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2006 | 143 | 0.020 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2006 | 109 | 0.020 |
Why?
|
| Kidney | 1 | 2014 | 2110 | 0.020 |
Why?
|
| Carbazoles | 1 | 2006 | 89 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 668 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2014 | 2926 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 16640 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 904 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 1867 | 0.010 |
Why?
|
| Cell Movement | 1 | 2006 | 2460 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 4939 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2006 | 4043 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 10695 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 5309 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2006 | 3662 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 14615 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 33691 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 12019 | 0.000 |
Why?
|
| Male | 1 | 2011 | 127917 | 0.000 |
Why?
|